Latest Company News

From high-end imaging and cardiovascular implants to diagnostics and surgical robotics, Chinese MedTech companies are moving rapidly up the value chain—and increasingly into global markets. This guide profiles 20 companies international executives should know, outlining what they make, where they compete and why they matter in 2026.

TIROMU raised tens of millions of RMB in Pre-A funding to advance clinical trials and registration filing for its fundus injection surgical robot, while continuing R&D on next-generation ophthalmic microsurgery systems.

China’s surgical robotics sector hits a turning point as Edge Medical Robotics reports RMB 301M gross profit and near profitability, signaling a shift from R&D-driven growth to sustainable commercialization.

Edge Medical listed in Hong Kong at a HKD 23.2 billion market cap, signaling its entry into global benchmarking for surgical robotics.